. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost-Benefit AnalysisErythroblastosis, Fetal/economicsErythroblastosis, Fetal/prevention & controlFemaleHumansInfant, NewbornIsoantibodiesPregnancyPrenatal Care/economicsRh-Hr Blood-Group System/immunology
Substances: See more » IsoantibodiesRh-Hr Blood-Group System
Year: 1981 PMID: 6781610 PMCID: PMC1504501 DOI: 10.1136/bmj.282.6265.676
Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN: 0267-0623